TherapeuticsSeptember 1, 1997Oral and intravenous methylprednisolone were equally efficacious for relapses in multiple sclerosisT. Jock Murray, OC, MDT. Jock Murray, OC, MDDalhousie University, Halifax, Nova Scotia, Canada (T.J.M.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1997-127-2-038 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationBarnes D, Hughes RA, Morris RW, et al. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet. 1997 Mar 29;349:902-6.References1 Thompson AJ, Kennard C, Swash M, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 1989;39:969-71. Google Scholar2 Milligan NM, Newcombe R, Compston DA. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987;50:511-6. Google Scholar Author, Article, and Disclosure InformationAffiliations: Dalhousie University, Halifax, Nova Scotia, Canada (T.J.M.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails September 1, 1997Volume 127, Issue 2Page: 38KeywordsClinical trialsDrugsEvoked potentialsGlucoseImmunosuppressivesMagnetic resonance imagingMultiple sclerosisSteroid therapySteroidsWalking ePublished: 9 March 2020 Issue Published: September 1, 1997 Copyright & PermissionsCopyright © 1997 by American College of Physicians. All Rights Reserved.Loading ...